Concerto HealthAI to Present AI Model for Identifying Metastatic Status of Cancer Patients with High Accuracy Using Structured EHR Data at ISPOR 2019

Compared to business rules alone, the model correctly identified 32% more metastatic breast cancer cases; Substantial time and resource savings for life science research

May 14, 2019

Read more

Astellas and Concerto HealthAI to Launch Real-World Evidence Initiative on Acute Myeloid Leukemia Focused on Improving Patient Treatment and Outcomes

Harnessing Real-World Data and advanced Outcomes Science to understand AML treatment patterns, disease progression, opportunities

April 10, 2019

Read more

Concerto HealthAI Enters Precision Oncology Collaboration with Pfizer

Integration of Concerto HealthAI’s Real-World Data and Advanced AI Capabilities Will Accelerate Patient Insights and Outcomes Studies

April 9, 2019

Read more

Bristol-Myers Squibb and Concerto HealthAI Announce Strategic Agreement to Broaden Uses of Real-World Evidence and Accelerate Precision Oncology Innovations

Multi-year strategic agreement that will cover a diverse range of cancers, integrate multiple data sources, and apply AI and machine learning to accelerate next-generation research models

March 28, 2019

Read more

3 Senior Data Scientists Join Concerto HealthAI to Lead Innovation in AI and Deep Learning Applications for Life Sciences

44 Patents Filed or Granted Among Three New Hires with Deep Expertise in AI Research, Validation and Application Development

March 4, 2019

Read more

Concerto HealthAI to Present at J.P. Morgan’s 37th Annual Healthcare Conference

New CEO to Focus on Enterprise-Level Transformation of Healthcare Industry Through Real World Evidence Solutions and AI Insights Platform

January, 7, 2019

Read more

CancerLinQ LLC, Concerto HealthAI, and Tempus are Expanding Collaboration with U.S. Food and Drug Administration on Checkpoint Inhibitors

Technology Companies Concerto HealthAI and Tempus Join to Conduct Data Analysis

August 22, 2018

Read more
Read more